Veterinary Medicines

Feligen CRP liofilizāts un šķīdinātājs suspensijas injekcijām pagatavošanai kaķiem

Authorised
  • Feline calicivirus, strain F9, Live
  • Felid herpesvirus 1, strain F2, Live
  • Feline panleucopenia virus, strain LR 72, Live
Download as PDF

Product identification

Medicine name:
Feligen CRP liofilizāts un šķīdinātājs suspensijas injekcijām pagatavošanai kaķiem
Active substance:
  • Feline calicivirus, strain F9, Live
  • Felid herpesvirus 1, strain F2, Live
  • Feline panleucopenia virus, strain LR 72, Live
Target species:
  • Cat
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Feline calicivirus, strain F9, Live
    1258930.00
    cell culture infective dose 50
    /
    1.00
    unit(s)
  • Felid herpesvirus 1, strain F2, Live
    3981070.00
    cell culture infective dose 50
    /
    1.00
    unit(s)
  • Feline panleucopenia virus, strain LR 72, Live
    31622.80
    cell culture infective dose 50
    /
    1.00
    unit(s)
Pharmaceutical form:
  • Lyophilisate and solvent for suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI06AD04
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Latvia
Available in:
  • Latvia
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Virbac
Marketing authorisation date:
Manufacturing sites for batch release:
  • Virbac
Responsible authority:
  • Food And Veterinary Service
Authorisation number:
  • V/NRP/08/1606
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Latvian (PDF)
Published on: 2/09/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."